Patents by Inventor Mattan Hurevich

Mattan Hurevich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240287128
    Abstract: The present disclosure generally relates to the field of solid phase synthesis and methods for synthesizing peptides and employing solid phase synthesis.
    Type: Application
    Filed: November 17, 2021
    Publication date: August 29, 2024
    Inventors: Chaim GILON, Mattan HUREVICH, Moshe BENTOLILA, Israel ALSHANSKI, Johnny NAOUM
  • Publication number: 20210190720
    Abstract: The invention provides robust, highly sensitive sensors for detecting and determining the presence and quantity of biologically important metal ions in a biological/physiological sample, by utilizing metal binding peptides immobilized on a surface.
    Type: Application
    Filed: August 23, 2018
    Publication date: June 24, 2021
    Inventors: Shlomo Yitzchaik, Chaim Gilon, Mattan Hurevich, Marx Gerard
  • Publication number: 20200010502
    Abstract: The present invention relates to a new approach for the synthesis of multiphosphorylated peptides. Specifically, the present invention provides a process, which enables the synthesis of multiphosphorylated peptides with up to seven phosphorylated Serine (pSer) and Threonine (pThr) residues, including such residues that are close in sequence.
    Type: Application
    Filed: July 3, 2019
    Publication date: January 9, 2020
    Inventors: Assaf FRIEDLER, Samara simha reddy MAMDI, Mattan HUREVICH
  • Publication number: 20140336127
    Abstract: Peptide helices stabilized by backbone cyclization which are capable of inhibiting dimerization of the Chemokine (C-C motif) receptor 2 (CCR2), as well as pharmaceutical compositions including such backbone cyclized peptide helices. Use of pharmaceutical compositions and peptide helices in treatment of Multiple Sclerosis (MS) and other diseases associated with CCR2 activation.
    Type: Application
    Filed: July 23, 2014
    Publication date: November 13, 2014
    Inventors: Chaim Gilon, Maya Ratner-Hurevich, Mattan Hurevich
  • Publication number: 20120270774
    Abstract: The present invention relates to backbone cyclized CD-4 mimetics and to compositions and methods comprising them for preventing and treating viral infection. In particular, the present invention relates to orally bio-available compounds and formulations for prevention and treatment of human HIV-1 infection.
    Type: Application
    Filed: August 29, 2010
    Publication date: October 25, 2012
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem LTd
    Inventors: Chaim Gilon, Amnon Hoffman, Moshe Kotler, Mattan Hurevich, Salim Joubran, Avi Swed